Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Zenas BioPharma granted 74,900 RSUs to newly hired employees on October 15, 2026, as inducement awards under Nasdaq Listing Rule 5635(c)(4). The RSUs vest in four equal annual installments through 2030 and are tied to continued service with the company.
Key figures
- Rsus granted
- 74900
- Vesting schedule
- 4 equal annual installments beginning October 15, 2027
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.